Tripletail Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
2,026
-27
-1% -$3.16K 0.3% 66
2026
Q1
$248K Sell
2,053
-169
-8% -$19.5K 0.34% 62
2025
Q4
$234K Sell
2,222
-335
-13% -$31.4K 0.3% 64
2025
Q3
$225K Sell
2,557
-128
-5% -$10.5K 0.27% 67
2025
Q2
$215K Buy
+2,685
New +$213K 0.31% 68

Other funds holding MRK

Tripletail Wealth Management's MRK Position: Q2 2026 in Review

Tripletail Wealth Management reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $3.16K and leaving 2,026 shares worth $262K. The position accounts for 0.3% of the portfolio, ranked #66.

Tripletail Wealth Management first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tripletail Wealth Management held 2,026 shares of Merck worth $262K as of Q2 2026.
  • Tripletail Wealth Management sold 27 Merck shares in Q2 2026, an estimated $3.16K.
  • Merck made up 0.3% of Tripletail Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Tripletail Wealth Management first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.